ARTT Center of Excellence UT Health San Antonio




Addiction Research, Treatment & Training
Center of Excellence

the ARTT of Translational Science

Addiction Journal Club


All Addiction Journal Club sessions will be held from 4:00 - 5:00 PM on the second and fourth Tuesday of each month in the Pharmacology Large Conference Room (229B) unless otherwise noted

Sign Up to Present at the Addiction Journal Club

Date
(Presenter)
Article
November 12, 2019 TBD
November 26, 2019 No Addiction Journal Club
December 3, 2019 TBD
December 24, 2019 No Addiction Journal Club
January 14, 2020 TBD
January 28, 2020 TBD


Past Journal Clubs

Date
(Presenter)
Article
October 8, 2019 A G protein signaling-biased agonist at the μ-opioid receptor reverses morphine tolerance while preventing morphine withdrawal
October 22, 2019 No Addiction Journal Club
September 24, 2019 Conjugate vaccine produces long-lasting attenuation of fentanyl vs. food choice and blocks expression of opioid withdrawal-induced increases in fentanyl choice in rats
August 27, 2019 No Addiction Journal Club
September 10, 2019 No Addiction Journal Club
August 13, 2019
(Gilman)
The Neurobiological Underpinnings of Obesity and Binge Eating: A Rationale for Adopting the Food Addiction Model
July 23, 2019
(Gerak)
Operant Social Reward Decreases Incubation of Heroin Craving in Male and Female Rats
July 9, 2019
Does cannabis legalisation change healthcare utilisation? A population based study using the healthcare cost and utilisation project in Colorado, USA
June 25, 2019
  1. Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
  2. Association between medical cannabis laws and opioid overdose mortality has reversed over time
June 11, 2019

Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial.

May 28, 2019

Can CBD Really Do All That?

May 14, 2019
(Alex Wasserman, PhD)

Combined cognitive and parent training interventions for adolescents with ADHD and their mothers: A randomized control trial
23 April
(Donald Dougherty, PhD)
Reciprocal Relationships Between Parenting Behavior
and Disruptive Psychopathology from Childhood
Through Adolescence

Please note room change - This will be held in the Cellular and Integrative Physiology large conference room (3.078V)
12 March
(TJ Moon)
The Role of Behavioral Phenotypes on Impaired Driving
Recidivism Risk and Treatment Response to Brief
Intervention: A Preliminary Study
26 March
(Charles Mathias, PhD)
Mandating Treatment Based on Interlock Performance:
Evidence for Effectiveness
9 April
No Addiction Journal Club
12 February
(Kelly McGlothen-Bell,
Lisa Cleveland)
  1. Caring for Pregnant Women with Opioid Use Disorder in the USA: Expanding and Improving Treatment
  2. News Brief: US Legislators Take a Scattered Approach to Neonatal Abstinence Syndrome
26 February
(Kelly McGlothen-Bell, Lisa Cleveland)
  1. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome A Randomized Clinical Trial
  2. An Initiative to Improve the Quality of Care of Infants With Neonatal Abstinence Syndrome
22 January
(Jennifer Potter)
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial
08 January
(Kristen Rosen)
Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment
27 November
(Lynette Daws &
Lee Gilman)
Corticosterone Potentiation of Cocaine-Induced Reinstatement of Conditioned Place Preference in Mice is Mediated by Blockade of the Organic Cation Transporter 3
13 November
(Lynette Daws &
Lee Gilman)
Corticosterone Acts in the Nucleus Accumbens to Enhance Dopamine Signaling and Potentiate Reinstatement of Cocaine Seeking
23 October
Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016
9 October
(Lisa Gerak)
A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates
25 September
(Vanessa Minervini)
  1. Loperamide misuse and abuse
  2. Isopropyl Alcohol Swabs as a Preferred Substance of Abuse
11 September
A molecular mechanism for choosing alcohol over an alternative reward

Cannabidiol Series

Date
(Presenter)
Article
10 July
(Sabrina Blackledge)
Oral cannabidiol does not alter the subjective, reinforcing or cardiovascular effects of smoked cannabis.
26 June
(Brett Ginsburg)
Cannabidiol attenuates the appetitive effects of Δ 9-tetrahydrocannabinol in humans smoking their chosen cannabis
12 June
No Journal Club due to CPDD
22 May
(Brenda Gannon)
Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Δ9-tetrahydrocannabinol
8 May
(David Maguire)
Cannabidiol potentiates Δ 9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.
24 April
No Journal Club due to EB
10 April
(Lisa Gerak)
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro

Targeted deep brain stimulation for the treatment of addiction

Date Article
6 February Spotlight on pain: optogenetic approaches for interrogating somatosensory circuits
20 February Refining deep brain stimulation to emulate optogenetic treatment of synaptic pathology
6 March Rehabilitating the addicted brain with transcranial
magnetic stimulation
20 March High frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex for methamphetamine use disorders: A randomised clinical trial

Kratom Series

Date Article
7 November Review: Neurobiology of Kratom and its main alkaloid mitragynine
28 November Antinociceptive effect of 7-hydroxymitragynine in mice:
Discovery of an orally active opioid analgesic from the
Thai medicinal herb Mitragyna speciosa
12 December Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program
9 January

Withdrawal of Notice of Intent to Temporarily Place Mitragynine and 7-Hydroxymitragynine Into Schedule I

DEA Announces Intent to Schedule Kratom

Kratom Drug Ban May Cripple Promising Painkiller Research

Kratom: The Bitter Plant that Could Help Opioid Addicts—if the DEA doesn't ban it

Related Articles to this topic: What happens if kratom becomes illegal?